Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Ahlqvist

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Chemical Communications (Cambridge, England)|September 18, 2018
Exploring physicochemical space via a bioisostere of the trifluoromethyl and ethyl groups (BITE): attenuating lipophilicity in fluorinated analogues of Gilenya® for multiple sclerosisNathalie Erdeljac, Gerald Kehr, Marie Ahlqvist, et al.
Rapid Communications in Mass Spectrometry : RCM|October 8, 2015
Software-aided structural elucidation in drug discoveryMarie Ahlqvist, Carina Leandersson, Martin A Hayes, et al.
Molecular Pharmaceutics|October 21, 2025
Metabolite Identification Data in Drug Discovery, Part 2: Site-of-Metabolism Annotation, Analysis, and Exploration for Machine LearningYa Chen, Susanne Winiwarter, Roxane Axel Jacob, et al.
Clinical Pharmacology in Drug Development|March 17, 2017
Effects of Tenapanor on Cytochrome P450-Mediated Drug-Drug InteractionsSusanne Johansson, David P Rosenbaum, Marie Ahlqvist, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 7, 2017
Fluorine-Directed Glycosylation Enables the Stereocontrolled Synthesis of Selective SGLT2 Inhibitors for Type II DiabetesAnna Sadurní, Gerald Kehr, Marie Ahlqvist, et al.
Organic Letters|August 10, 2019
Stereocontrolled Synthesis of Tetrafluoropentanols: Multivicinal Fluorinated Alkane Units for Drug DiscoveryPatrick Bentler, Nathalie Erdeljac, Kathrin Bussmann, et al.
Molecular Pharmaceutics|October 14, 2025
Metabolite Identification Data in Drug Discovery, Part 1: Data Generation and Trend AnalysisMarie Ahlqvist, Isabella Bonner Karlsson, Anja Ekdahl, et al.
International Journal of Molecular Sciences|February 13, 2025
Investigation of Biotransformation Pathways in a Chimeric Mouse with a Humanized LiverIsabella B Karlsson, Anja Ekdahl, Hugh Etchingham-Coll, et al.
Biochemical Pharmacology|June 29, 2018
Critical differences in drug metabolic properties of human hepatic cellular models, including primary human hepatocytes, stem cell derived hepatocytes, and hepatoma cell linesAlexander J Kvist, Kajsa P Kanebratt, Anna Walentinsson, et al.
Journal of Medicinal Chemistry|July 30, 2024
Structural and Physicochemical Features of Oral PROTACsMarkus Schade, James S Scott, Thomas G Hayhow, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Chemical Communications (Cambridge, England)|September 18, 2018
Exploring physicochemical space via a bioisostere of the trifluoromethyl and ethyl groups (BITE): attenuating lipophilicity in fluorinated analogues of Gilenya® for multiple sclerosisNathalie Erdeljac, Gerald Kehr, Marie Ahlqvist, et al.
Rapid Communications in Mass Spectrometry : RCM|October 8, 2015
Software-aided structural elucidation in drug discoveryMarie Ahlqvist, Carina Leandersson, Martin A Hayes, et al.
Molecular Pharmaceutics|October 21, 2025
Metabolite Identification Data in Drug Discovery, Part 2: Site-of-Metabolism Annotation, Analysis, and Exploration for Machine LearningYa Chen, Susanne Winiwarter, Roxane Axel Jacob, et al.
Clinical Pharmacology in Drug Development|March 17, 2017
Effects of Tenapanor on Cytochrome P450-Mediated Drug-Drug InteractionsSusanne Johansson, David P Rosenbaum, Marie Ahlqvist, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 7, 2017
Fluorine-Directed Glycosylation Enables the Stereocontrolled Synthesis of Selective SGLT2 Inhibitors for Type II DiabetesAnna Sadurní, Gerald Kehr, Marie Ahlqvist, et al.
Organic Letters|August 10, 2019
Stereocontrolled Synthesis of Tetrafluoropentanols: Multivicinal Fluorinated Alkane Units for Drug DiscoveryPatrick Bentler, Nathalie Erdeljac, Kathrin Bussmann, et al.
Molecular Pharmaceutics|October 14, 2025
Metabolite Identification Data in Drug Discovery, Part 1: Data Generation and Trend AnalysisMarie Ahlqvist, Isabella Bonner Karlsson, Anja Ekdahl, et al.
International Journal of Molecular Sciences|February 13, 2025
Investigation of Biotransformation Pathways in a Chimeric Mouse with a Humanized LiverIsabella B Karlsson, Anja Ekdahl, Hugh Etchingham-Coll, et al.
Biochemical Pharmacology|June 29, 2018
Critical differences in drug metabolic properties of human hepatic cellular models, including primary human hepatocytes, stem cell derived hepatocytes, and hepatoma cell linesAlexander J Kvist, Kajsa P Kanebratt, Anna Walentinsson, et al.
Journal of Medicinal Chemistry|July 30, 2024
Structural and Physicochemical Features of Oral PROTACsMarkus Schade, James S Scott, Thomas G Hayhow, et al.
Pageof 2